Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Clobetasol Propionate Spray Versus Vehicle for the Management of Moderate to Severe Plaque Psoriasis of the Scalp
The primary objective of this study is to evaluate the safety and efficacy of clobetasol propionate spray versus vehicle spray for the management of moderate to severe plaque psoriasis of the scalp.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Dermatology Research Associates
Los Angeles, California, United States
Hudson Dermatology
Evansville, Indiana, United States
Research Division of The Skin Specialty Group
New York, New York, United States
Dermatology Associates, PLLC
Seattle, Washington, United States
Start Date
April 1, 2009
Primary Completion Date
December 1, 2009
Completion Date
December 1, 2009
Last Updated
August 25, 2022
81
ACTUAL participants
clobetasol propionate spray 0.05%
DRUG
Vehicle spray
DRUG
Lead Sponsor
Galderma R&D
NCT05969223
NCT01195831
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06015152